lysicamine has been researched along with oxopurpureine in 1 studies
| Studies (lysicamine) | Trials (lysicamine) | Recent Studies (post-2010) (lysicamine) | Studies (oxopurpureine) | Trials (oxopurpureine) | Recent Studies (post-2010) (oxopurpureine) |
|---|---|---|---|---|---|
| 21 | 0 | 8 | 5 | 0 | 2 |
| Protein | Taxonomy | lysicamine (IC50) | oxopurpureine (IC50) |
|---|---|---|---|
| hexokinase HKDC1 | Homo sapiens (human) | 11.1 | |
| Female germline-specific tumor suppressor gld-1 | Caenorhabditis elegans | 6.152 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, FR; Teng, CM; Wei, JL; Wu, YC | 1 |
1 other study(ies) available for lysicamine and oxopurpureine
| Article | Year |
|---|---|
Antiplatelet aggregation constituents from Annona purpurea.
Topics: Alkaloids; Animals; Apomorphine; Aporphines; Chromatography, High Pressure Liquid; In Vitro Techniques; Plants, Medicinal; Platelet Aggregation Inhibitors; Rabbits; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet | 1998 |